Business Context and Reporting Period
This Form 8-K Current Report is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) for the reporting period ending February 28, 2024. The filing primarily addresses corporate governance changes, specifically the appointment of a new independent director to fill a vacancy on the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on personnel appointments rather than financial performance results.
Material Changes
- Board Appointment: Blair Jordan was appointed as a Class II independent director effective February 28, 2024.
- Board Composition: The Board temporarily set the number of directors at four (4) while seeking additional independent members to fill prior vacancies.
- Committee Assignments: Mr. Jordan was appointed to the Audit, Compensation, Nominating and Corporate Governance, and Risk, Safety and Regulatory Committees. He was also named Chairperson of the Strategy and Alternatives Committee and Lead Independent Director.
Compensation and Outlook
Compensation Arrangements:
- Annual Retainer: $40,000 for Board service.
- Committee Fees: $10,000 for Chair of Strategy and Alternatives Committee; $15,000 for Lead Director.
- Payment Terms: An initial payment of $7,500 was made. Subsequent payments are quarterly in arrears. Crucially, 50% of the aggregate cash compensation is accrued until the Company raises an aggregate of $1 million from any source (debt, equity, insurance, litigation, etc.).
Management Commentary: The Board concluded Mr. Jordan is well-qualified due to his significant experience in restructuring, mergers and acquisitions, and his background as a senior executive and corporate director in various sectors including biotech and mining.
Investor Verification Checklist
- Verify the Company's current cash position and ability to meet the $1 million fundraising threshold required to release accrued director compensation.
- Confirm the status of other Board vacancies and the timeline for filling them to reach a fully staffed Board.
- Review the attached Offer Letter (Exhibit 10.1) for full terms of the indemnification and compensation agreement.
- Assess Mr. Jordan's prior involvement with Ascent Industries Corp. during its 2019 creditor protection proceedings (CCAA) as disclosed in his biography.